Cell Isolation/Cell Separation Market (2018-2024)

Cell isolation or separation is a tool used to sort cells into specific population from heterogeneous group of cells without contamination. The isolation of cells depends on properties of cells such as surface charge and adhesion, cell size and density, surface markers, and few others. The use of cell isolation techniques helps to open the door of cell-based therapies and thereby improve the quality of treatment and clinical outcome. Factors such as increasing incidence & prevalence of chronic diseases with aging population, technological advancement in cell isolation, growing demand for biopharmaceuticals and personalized medicine, and increasing stem cell research are driving cell isolation/cell separation market. Moreover, Asian countries and growing use of microfluidics technology will provide high opportunities for this market during forecast period. On the other hand, ethical issues regarding isolation of embryonic stem cells and high cost of cell separation instruments are expected to restrict the growth of this market.

The cell isolation/cell separation market is segmented by product [consumables (reagents and kits, beads and microspheres, media and sera, disposables), instruments (centrifuges, filtration systems, flow cytometer, magnetic-activated cell sorter)], cell type (human cells, animal cells, and others), technology (centrifugation, filtration, surface marker cell isolation), application (isolation of biomolecules, research, diagnostics, therapeutics, and others), end user (pharmaceutical & biotechnology companies, hospitals and diagnostic labs, academic and research institutes, and cell banks), and geography.

Based on product, consumables accounted for the largest share of global cell isolation/cell separation market in 2018 due to their repeated usage and procurement for various applications such as research, diagnostics, therapeutics, and others.

On the basis of cell type, human cells are expected to grow at fastest rate owing to growing number of chronic diseases and advancement in cell isolation techniques.

Based on application, isolation of biomolecules accounted for the largest share of global cell isolation/cell separation market in 2018. This is mainly due to increasing investment in biopharmaceutical production and personalized medicines by various end users.

On the basis of geographical analysis, North America including U.S. and Canada is anticipating being the largest market due to well-established healthcare system in the region, higher acceptance of advanced technologies, raising non-communicable diseases, rise in pharmaceutical & biotech research, higher stem cell research funding, and presence of key players. Moreover, Asia Pacific is expected to grow at fastest CAGR due to rapidly developing economies, growing aging population coupled with the rising prevalence of chronic diseases, on-going capacity expansions by pharmaceutical & biotechnology manufacturers, and investment from government & non-government bodies in biotechnology sector.

Stem cell based research is continuously growing by passing various hurdles. Moreover, researchers have been scaled back their use of animal models as these stem cells give better path for studying human diseases. The cell based diagnostic tool offers a more accurate representation of the real-life model than animal-based model. Also, it reduces the time span and expenses in drug discovery compared to animal-based diagnosis. Thus, their potential will lead to reshape the biological concepts and start to move them into clinic within next few years.

What factors contribute to the infrequent usage of overall cell isolation/cell separation consumables & instruments in cell banks?

Which geographic segment is expected to experience the fastest growth in the usage of cell isolation/cell separation consumables & instruments in pharmaceutical & biotechnology companies?

How does the penetration of cell isolation/cell separation consumables & instruments differ from other end users such as hospitals and diagnostic labs, academic and research institutes, and cell banks?

What are the top competitors in this market and what strategies do they employ to gain shares?

What is driving growth and which market segments have the most potential for revenue expansion over the forecast period?

What strategies should new companies look to enter this market use to compete effectively?

What are the major drivers, restraints and opportunities in the cell isolation/cell separation market?

Who are the major players in various countries and what share of the market do they hold?

What are the geographical trends and high growth regions/ countries?

What companies have recently merged/acquired and how will these unions affect the competitive landscape of the cell isolation/cell separation market?

What companies have created partnerships and how will these partnerships promote a competitive advantage?

Who are the major players in the global cell isolation/cell separation market and what share of the market do they hold?

What are the local emerging players in the global cell isolation/cell separation market and how do they compete with the global players?